Prognostic factors for EGFRm NSCLC receiving first-line EGFR-TKIs are explored.
Age, mutation, performance status and number of metastases are found to affect PFS.
Blood lymphocyte to monocyte ratio also independently affect PFS.
PFS score is created on a test dataset, and is validated on a validation dataset.